N/A N=135 Reducing Adolescent Pregnancy
Pregnancy in Adolescence · Counseling · Contraception Behavior
Primary: Intention to Initiate Contraception — 59 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=146 Reducing Teen Pregnancy in the Emergency Department
Reproductive Behavior · Sexual Behavior · Adolescent Behavior
Primary: Potential Efficacy: Effective Contraception Initiation Rates [Time Frame: Enrollment, 12 Weeks Post-enrollment (2 Weeks Post Close of Intervention)] — 14; 14 Participants
N/A N=700 Ulipristal Emergency Contraception Used Before or After Ovulation
Contraception
Primary: Percentage of Pregnancies Prevented (PPP) — 77.5; 36.9 percentage of pregnancies prevented — p=<0.0001
Phase 3 N=2,858 A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy
Contraception · Female Contraception
Primary: All Users Pregnancy Rates Based on Pearl Index (PI) Analyses for 28-Day Cycles and Broken Out by Subpopulations Defined by Participant Weight, Using the 7-Day Rule…
Phase 3 N=3,597 A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy
Pregnancy Prevention
Primary: All Users Pregnancy Rates Based on Pearl Index (PI) Analyses for 91-Day Cycles and Broken Out by Subpopulations Defined by Participant Weight — 2.82; 2.46; 4.54…
N/A N=138 Improving Effective Contraceptive Use Among Opioid-maintained Women: Stage II
Contraceptive Usage · Opioid Dependence
Primary: Percentage of Participants With Verified Prescription Contraceptive Use at the 6-month Assessment — 5; 14; 23 Participants — p=<.001
N/A N=246 Contraceptive Counseling Following an Abortion
Post Abortion Care
Primary: Contraceptive Acceptability and Use of Contraceptives During the 6-month Follow-up — 121; 86 participants
Phase 3 N=36 Oral Progesterone for Prevention of Preterm Birth
Preterm Birth
Primary: Rate of Recurrent Preterm Birth — 5; 8 participants
N/A N=144 The Use of Progesterone to Reduce Preterm Birth
Preterm Birth
Primary: Weeks Gestation at Birth Among Patients Receiving the Active Drug. — 31.9; 30.2 weeks
N/A N=272 Contraceptive Awareness and Reproductive Education
Pregnancy · Sexually Transmitted Infections
Primary: Number of Participants With Continuous Use of Highly Effective Contraceptives Over 9 Months. — 39; 29 Participants — p=>.05
Phase 3 N=3,324 Study of Contraceptive Efficacy & Safety of Phexxi™ (Previously Known as Amphora) Gel Compared to Conceptrol Vaginal Gel
Contraception
Primary: 6-Month (183 Days) Cumulative Pregnancy Percentage — 10.0; 10.5 pregnancy percentage
Phase 3 N=1,533 Safety and Efficacy of CDB-2914 for Emergency Contraception
Emergency Contraception
Primary: Pregnancy Rate — 2.1 percentage of participants
N/A N=96 Contraception and Pregnancy in Diabetes Mellitus
Diabetes Mellitus, Type 1 · Contraception
Primary: Number of Women 'Prepared for Pregnancy\ — 3 participants
N/A N=385 Prevention of Preterm Birth Using Cervical Pessary in Pregnant Women With Short Cervix
Preterm Birth
Primary: Spontaneous Delivery Before 34 Completed Weeks — 51; 12 Participants
Early Phase 1 N=40 Ovarian Function With ENG Implant and UPA Use
Contraception
Primary: Number of Participants With Ovulation With Implant-alone — 7; 0 Participants
N/A N=119 Improving Reproductive Health for Women in Opioid Medication-Assisted Treatment (OMAT)
Contraception
Primary: Family Planning Visit and Long-acting Reversible Contraception Use at Three and Six Month Follow-up by Condition. — 2; 7; 2; 7 Participants
N/A N=122 Prevention of Preterm Birth With a Pessary in Singleton Gestations
Preterm Birth · Short Cervix
Primary: Number of Subjects Experiencing Preterm Birth — 26; 23 Participants
N/A N=2,402 Enhancing Male Participation in Interventions to Prevent Unintended Pregnancy
Contraception
Primary: Number of Non-pregnant Couples With Modern Contraceptive Use in Past 3 Months — 265; 295 Couple
N/A N=37 Reducing Adolescent Pregnancy in the Emergency Department
Contraception · Adolescent Behavior · Emergency Department
Primary: Adolescent Feasibility of Intervention — 4.5; 4.7 score on a scale
Phase 4 N=4,447 PrEP Implementation for Mothers in Antenatal Care
HIV Infections · Pregnancy Related
Primary: Maternal HIV Incidence — 0.38; 0.31 incidence/100 Person years
N/A N=321 A Comparison of Continuation Rates for Three Hormonal Contraceptive Methods
Contraception
Primary: Continuation Rates — 82; 78; 83 participants
Phase 2 N=271 Efficacy Study of a Cervical Pessary Containing Progesterone for the Prevention of Preterm Delivery
Preterm Birth
Primary: Number of Participants Not Giving Birth Before Week 32 and Week 34 of Gestation — 73; 71; 67; 66 Participants
N/A N=168 Initiating Contraception After Emergency Contraception From Pharmacy
Contraceptive Use After Emergency Contraception
Primary: Self-reported Uptake of Effective Ongoing Contraception (Not Condoms) — 5; 13; 22; 0 participants — p=<0.001
Phase 4 N=50 Advance Supply of Emergency Contraception Compared to Routine Postpartum Care in Teens
Post Partum
Primary: ABILITY TO FOLLOW POSTPARTUM TEENS FOR 1 YEAR. — 22; 16 Participants
Phase 3 N=2,221 Safety and Efficacy of CDB-2914 in Comparison to Levonorgestrel for Emergency Contraception
Contraception
Primary: Number of Participants With Pregnancy — 20; 30 Participants
N/A N=984 MyNewOptions: An Online Study of Reproductive Life Planning and Contraceptive Action Planning
Contraceptive Use · Unintended Pregnancy
Primary: Contraceptive Use — 93.43; 94.46; 94.10 percentage of surveys — p=1.0
N/A N=100 The Impact of Contraception on Postpartum Weight Loss
Weight
Primary: Weight — 3.2; 6.8; 7.0 percent weight lost — p=<0.05
Phase 2 N=80 Evaluating the Pharmacokinetics, Feasibility, Acceptability, and Safety of Oral Pre-Exposure Prophylaxis for HIV Prevention During Pregnancy and Postpartum
HIV Infections
Primary: Estimated Threshold of Maternal Steady-state Tenofovir Diphosphate (TFV-DP) Concentration Levels Corresponding to Optimal Adherence in the PK Component — 965; 1050…
Phase 3 N=72 Pericoital Oral Contraception With Levonorgestrel
Healthy
Primary: Efficacy: the Pearl Index (Number of Pregnancies Per 100 Woman-years) in the Primary Evaluable Population (18-35) — 22.4 pregnancies per 100 woman years
N/A N=20 Patient Centered Postpartum Contraception App
Contraceptive Usage
Primary: Feasibility of Application — 4.47; 4.52; 4.16; 4.26 units on a scale